Prednisolone and prednisone are integral components of induction and maintenance
immunosuppressive regimens in solid organ transplantation. The pharmacokinetics of these …

Since the first heart transplantation (HT) in 1967, survival has steadily improved. Issues
related to over-and under-immunosuppression are, however, still common following HT …

CHAIR: Costanzo MR: Midwest Heart Foundation, Lombard Illinois, USA TASK FORCE 1:
Dipchand A: Hospital for Sick Children, Toronto Ontario, Canada; Starling R: Cleveland …

Advances in maintenance immunosuppression over the past three decades have improved
solid organ transplantation outcomes dramatically. Uninterrupted access to …

1098 TOYODA Y et al. nors, and (2) coordinating the donation process when actual donors
become available. There are 58 OPOs in the United States. When donors become available …

In the 30 years since the rabbit antithymocyte globulin (rATG) Thymoglobulin® was first
licensed, its use in solid organ transplantation and hematology has expanded progressively …

The more than 25 years of clinical experience with rabbit antithymocyte globulin (rATG),
specifically Thymoglobulin®, has transformed immuno-suppression in solid organ …

The most modifiable risk factor for post-transplant lymphoproliferative disease (PTLD) is the
type and dose of induction and maintenance immunosuppressive therapy. It is challenging …

Approximately 50% of heart transplant programs currently employ a strategy of induction
therapy (IT) with either interleukin-2 receptor antagonists (IL2RA) or polyclonal anti …

Background Heart transplantation has become a valuable and well‐accepted treatment
option for end‐stage heart failure. Rejection of the transplanted heart by the recipient's body …